Quality & complianceOfficial
FDA says clinical investigator's CAPA response falls short after CBER warning letter
🇺🇸 FDA CBER · Fri 20 Nov 2026
CBER told Florida-based Stephen J. Fallon, Ph.D., that his reply to an August warning letter did not fully resolve the violations and that he must submit a comprehensive CAPA plan.
The US Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) has told clinical investigator Stephen J. Fallon, Ph.D., of Wilton Manors, Florida, that his response to a warning letter did not completely resolve the issues raised. The letter is listed under ID 728673 and dated 13 November 2026. It was published on 20 November.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (FDA CBER). AI-assisted; check the source before acting.
More Quality & compliance
All →
Terumo Aortic recalls all in-date Relay Pro and Treo stent-graft systems over endotoxin risk
🇨🇦 Health Canada · Fri 20 Nov 2026
BfArM publishes GE Healthcare urgent field safety notice for Centricity PACS and Enterprise Archive
🇩🇪 BfArM field safety notices · Fri 20 Nov 2026
New Jersey health centre owner jailed for 180 days over billing fraud and unlicensed practice
🇺🇸 HHS OIG · Fri 20 Nov 2026
Richmond couple sentenced over Medicaid mental health billing scheme worth nearly $1m
🇺🇸 HHS OIG · Fri 20 Nov 2026
InnovAge settles Colorado Medicaid false claims allegations over senior care services
🇺🇸 HHS OIG · Fri 20 Nov 2026
Michigan Home Health Agency Owner Gets Four Years in Prison for $1.6m Medicare Fraud
🇺🇸 HHS OIG · Fri 20 Nov 2026